Global Subcutaneous Injection Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Subcutaneous Injection Revenue
• 1.4 Market by Type
  • 1.4.1 Global Subcutaneous Injection Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Subcutaneous Injection Equipment
  • 1.4.3 Subcutaneous Injection Drug
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global Subcutaneous Injection Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Laboratory
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Subcutaneous Injection Market Perspective (2015-2026)
• 2.2 Global Subcutaneous Injection Growth Trends by Regions
  • 2.2.1 Subcutaneous Injection Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Subcutaneous Injection Historic Market Share by Regions (2015-2020)
  • 2.2.3 Subcutaneous Injection Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Subcutaneous Injection Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Subcutaneous Injection Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Subcutaneous Injection Players by Market Size
  • 3.1.1 Global Top Subcutaneous Injection Players by Revenue (2015-2020)
  • 3.1.2 Global Subcutaneous Injection Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Subcutaneous Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Subcutaneous Injection Market Concentration Ratio
  • 3.2.1 Global Subcutaneous Injection Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Subcutaneous Injection Revenue in 2019
• 3.3 Subcutaneous Injection Key Players Head office and Area Served
• 3.4 Key Players Subcutaneous Injection Product Solution and Service
• 3.5 Date of Enter into Subcutaneous Injection Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Subcutaneous Injection Historic Market Size by Type (2015-2020)
• 4.2 Global Subcutaneous Injection Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Subcutaneous Injection Market Size by Application (2015-2020)
• 5.2 Global Subcutaneous Injection Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Subcutaneous Injection Market Size (2015-2020)
• 6.2 Subcutaneous Injection Key Players in North America (2019-2020)
• 6.3 North America Subcutaneous Injection Market Size by Type (2015-2020)
• 6.4 North America Subcutaneous Injection Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Subcutaneous Injection Market Size (2015-2020)
• 7.2 Subcutaneous Injection Key Players in Europe (2019-2020)
• 7.3 Europe Subcutaneous Injection Market Size by Type (2015-2020)
• 7.4 Europe Subcutaneous Injection Market Size by Application (2015-2020)

8 China

• 8.1 China Subcutaneous Injection Market Size (2015-2020)
• 8.2 Subcutaneous Injection Key Players in China (2019-2020)
• 8.3 China Subcutaneous Injection Market Size by Type (2015-2020)
• 8.4 China Subcutaneous Injection Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Subcutaneous Injection Market Size (2015-2020)
• 9.2 Subcutaneous Injection Key Players in Japan (2019-2020)
• 9.3 Japan Subcutaneous Injection Market Size by Type (2015-2020)
• 9.4 Japan Subcutaneous Injection Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Subcutaneous Injection Market Size (2015-2020)
• 10.2 Subcutaneous Injection Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Subcutaneous Injection Market Size by Type (2015-2020)
• 10.4 Southeast Asia Subcutaneous Injection Market Size by Application (2015-2020)

11 India

• 11.1 India Subcutaneous Injection Market Size (2015-2020)
• 11.2 Subcutaneous Injection Key Players in India (2019-2020)
• 11.3 India Subcutaneous Injection Market Size by Type (2015-2020)
• 11.4 India Subcutaneous Injection Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Subcutaneous Injection Market Size (2015-2020)
• 12.2 Subcutaneous Injection Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Subcutaneous Injection Market Size by Type (2015-2020)
• 12.4 Central & South America Subcutaneous Injection Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Becton Dickinson
  • 13.1.1 Becton Dickinson Company Details
  • 13.1.2 Becton Dickinson Business Overview
  • 13.1.3 Becton Dickinson Subcutaneous Injection Introduction
  • 13.1.4 Becton Dickinson Revenue in Subcutaneous Injection Business (2015-2020))
  • 13.1.5 Becton Dickinson Recent Development
• 13.2 Daiichi Sankyo
  • 13.2.1 Daiichi Sankyo Company Details
  • 13.2.2 Daiichi Sankyo Business Overview
  • 13.2.3 Daiichi Sankyo Subcutaneous Injection Introduction
  • 13.2.4 Daiichi Sankyo Revenue in Subcutaneous Injection Business (2015-2020)
  • 13.2.5 Daiichi Sankyo Recent Development
• 13.3 Sanofi
  • 13.3.1 Sanofi Company Details
  • 13.3.2 Sanofi Business Overview
  • 13.3.3 Sanofi Subcutaneous Injection Introduction
  • 13.3.4 Sanofi Revenue in Subcutaneous Injection Business (2015-2020)
  • 13.3.5 Sanofi Recent Development
• 13.4 Roche
  • 13.4.1 Roche Company Details
  • 13.4.2 Roche Business Overview
  • 13.4.3 Roche Subcutaneous Injection Introduction
  • 13.4.4 Roche Revenue in Subcutaneous Injection Business (2015-2020)
  • 13.4.5 Roche Recent Development
• 13.5 GSK
  • 13.5.1 GSK Company Details
  • 13.5.2 GSK Business Overview
  • 13.5.3 GSK Subcutaneous Injection Introduction
  • 13.5.4 GSK Revenue in Subcutaneous Injection Business (2015-2020)
  • 13.5.5 GSK Recent Development
• 13.6 Eli Lilly
  • 13.6.1 Eli Lilly Company Details
  • 13.6.2 Eli Lilly Business Overview
  • 13.6.3 Eli Lilly Subcutaneous Injection Introduction
  • 13.6.4 Eli Lilly Revenue in Subcutaneous Injection Business (2015-2020)
  • 13.6.5 Eli Lilly Recent Development
• 13.7 Asahi Kasei Pharma
  • 13.7.1 Asahi Kasei Pharma Company Details
  • 13.7.2 Asahi Kasei Pharma Business Overview
  • 13.7.3 Asahi Kasei Pharma Subcutaneous Injection Introduction
  • 13.7.4 Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2015-2020)
  • 13.7.5 Asahi Kasei Pharma Recent Development
• 13.8 Takeda Pharmaceutical
  • 13.8.1 Takeda Pharmaceutical Company Details
  • 13.8.2 Takeda Pharmaceutical Business Overview
  • 13.8.3 Takeda Pharmaceutical Subcutaneous Injection Introduction
  • 13.8.4 Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2015-2020)
  • 13.8.5 Takeda Pharmaceutical Recent Development
• 13.9 Antares Pharma, Inc.
  • 13.9.1 Antares Pharma, Inc. Company Details
  • 13.9.2 Antares Pharma, Inc. Business Overview
  • 13.9.3 Antares Pharma, Inc. Subcutaneous Injection Introduction
  • 13.9.4 Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2015-2020)
  • 13.9.5 Antares Pharma, Inc. Recent Development
• 13.10 Eisai Co.，Ltd
  • 13.10.1 Eisai Co.，Ltd Company Details
  • 13.10.2 Eisai Co.，Ltd Business Overview
  • 13.10.3 Eisai Co.，Ltd Subcutaneous Injection Introduction
  • 13.10.4 Eisai Co.，Ltd Revenue in Subcutaneous Injection Business (2015-2020)
  • 13.10.5 Eisai Co.，Ltd Recent Development
• 13.11 Chugai Pharmaceutical
  • 10.11.1 Chugai Pharmaceutical Company Details
  • 10.11.2 Chugai Pharmaceutical Business Overview
  • 10.11.3 Chugai Pharmaceutical Subcutaneous Injection Introduction
  • 10.11.4 Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2015-2020)
  • 10.11.5 Chugai Pharmaceutical Recent Development
• 13.12 Endo International
  • 10.12.1 Endo International Company Details
  • 10.12.2 Endo International Business Overview
  • 10.12.3 Endo International Subcutaneous Injection Introduction
  • 10.12.4 Endo International Revenue in Subcutaneous Injection Business (2015-2020)
  • 10.12.5 Endo International Recent Development
• 13.13 PenJet Corporation
  • 10.13.1 PenJet Corporation Company Details
  • 10.13.2 PenJet Corporation Business Overview
  • 10.13.3 PenJet Corporation Subcutaneous Injection Introduction
  • 10.13.4 PenJet Corporation Revenue in Subcutaneous Injection Business (2015-2020)
  • 10.13.5 PenJet Corporation Recent Development
• 13.14 Aspen Medical Group
  • 10.14.1 Aspen Medical Group Company Details
  • 10.14.2 Aspen Medical Group Business Overview
  • 10.14.3 Aspen Medical Group Subcutaneous Injection Introduction
  • 10.14.4 Aspen Medical Group Revenue in Subcutaneous Injection Business (2015-2020)
  • 10.14.5 Aspen Medical Group Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer